Elhan Webb, CFA, joined Rubius in November 2020 and serves as Vice President of Investor Relations. She brings more than 20 years of diverse international experience across investor relations, business development, investment analysis and portfolio management in the healthcare and biotechnology fields.
Prior to Rubius, Elhan was responsible for heading investor relations at Radius Health and Genfit. During her time at Roche, she led IR activities for Roche Diagnostics. She also held business development roles at Roche Molecular Diagnostics and Morphochem.
Earlier in her career, Elhan spent more than a decade in Europe managing and leading investments in the healthcare sector at financial institutions such as BB Biotech-Bellevue Asset Management, Cantrade-UBS and Lombard Odier.
Elhan is a CFA Charterholder and has an MBA from the University of Southern California and a B.A. in Economics from Bogazici University in Istanbul, Turkey.